We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PHAT market cap is 394.54M. The company's latest EPS is USD -2.9482 and P/E is -1.93.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 682k | 1.91M | 7.32M | 16.35M |
| Operating Income | -35.66M | -69.88M | -69.95M | -77.3M | -70.8M |
| Net Income | -43.24M | -79.57M | -82.85M | -91.45M | -85.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 682k |
| Operating Income | -106.22M | -125.67M | -135.08M | -172.44M | -167.31M |
| Net Income | -255.13M | -129.07M | -143.88M | -197.72M | -201.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 236.99M | 413.84M | 356.5M | 319.38M | 387.04M |
| Total Liabilities | 254.77M | 486.6M | 505M | 553.21M | 574.16M |
| Total Equity | -17.77M | -72.76M | -148.5M | -233.83M | -187.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 257.18M | 295.11M | 189.43M | 164.81M | 413.84M |
| Total Liabilities | 29.22M | 100.84M | 117.28M | 239.62M | 486.6M |
| Total Equity | 227.96M | 194.27M | 72.16M | -74.81M | -72.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -93.78M | -137.58M | -69.02M | -139.74M | -203.31M |
| Investing | -1.16M | -1.63M | -40k | -86k | -130k |
| Financing | 155.59M | 367.58M | 9.9M | 34.67M | 156.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.51M | -69.69M | -148.62M | -146.53M | -137.58M |
| Investing | -25.25M | -1.04M | -328k | -1.04M | -1.63M |
| Financing | 304.65M | 114.46M | 44.71M | 120.04M | 367.58M |
| Market Cap | 394.54M |
| Price to Earnings Ratio | -1.93 |
| Price to Sales Ratio | 569 |
| Price to Cash Ratio | 1.02 |
| Price to Book Ratio | -5.35 |
| Dividend Yield | - |
| Shares Outstanding | 68.38M |
| Average Volume (1 week) | 966.96k |
| Average Volume (1 Month) | 1.04M |
| 52 Week Change | -41.89% |
| 52 Week High | 19.71 |
| 52 Week Low | 5.21 |
| Spread (Intraday) | 0.06 (1.05%) |
| Company Name | Phathom Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.phathompharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
